SciELO - Scientific Electronic Library Online

 
vol.47 número3Análisis de percepción de riesgos laborales de tipo biológico con la utilización de un sistema informático especializadoLa auditoría interna y la calidad de la documentación de los ensayos clínicos en Cuba índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Cubana de Farmacia

versão impressa ISSN 0034-7515

Resumo

BURGUET LAGO, Nancy  e  TROCHE CONCEPCION, Yenilen. Working strategy to be followed in Liorad Laboratories for pharmacosurveillance since the industrial stage. Rev Cubana Farm [online]. 2013, vol.47, n.3, pp. 339-347. ISSN 0034-7515.

Introduction: pharmacosurveillance is a shared responsibility of the physicians, the pharmaceutical industry, the health authorities and the patients. However, Liorad Laboratories had not defined the implementation of this procedure yet. Objective: to establish the working strategy to be followed by the institution to put pharmacosurveillance into practice at the industrial level. Method: the outlined strategies were the selection of a person to take on responsibility for pharmacosurveillance, the definition of the regulatory framework to rule the same, setting up of the information flow, definition of the documentary system to obtain documented evidence and assessment of the design of aftermarket studies. Results: one specialist from the research, development and innovation division was appointed to lead the pharmacosurveillance activity as well as his/her working functions were drafted. The appointed professional was trained in industry-oriented pharmacosurveillance. The regulatory framework was defined as the set of rules governing this activity at domestic level. The documents required for facilitating the organization of this activity and recording all the work done were finally drafted, reviewed and approved. Finally, it was decided that the fundamental design to carry out the aftermarket studies would be based on the research of adverse, unusual and unexpected events and the detection of rises in the incidence of known adverse reactions. Conclusions: once the work is finished, there is an organizational infrastructure that enables the company to take on this task since the industrial phase, which will contribute to early detect unexpected events that could alter the risk-benefit balance of medicinal products manufactured at Liorad Laboratories.

Palavras-chave : pharmacosurveillance; adverse reactions; strategy.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License